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Two cases of delayed diagnosis of postpartal streptococcal
toxic shock syndrome
Wolfram Schummer and Claudia Schummer
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Background: Puerperal sepsis due to group A b-hemolytic streptococcal (GAS) toxic shock syndrome is
associated with very high morbidity and mortality. Luckily it is now rare, but diagnosis is not always easy. This
report demonstrates the problem of recognizing this disease, and summarizes the current knowledge on the
pathomechanism and management of streptococcal toxic shock syndrome.
Case: Two cases of postpartum streptococcal toxic shock syndrome due to GAS are described. In both cases
the correct diagnosis was delayed for several days. The first patient was sent home with the diagnosis of German
measles;the secondpatientwastransferredtoourneurologicalintensivecareunitwith the diagnosis of meningitis.
Both patients were admitted to the intensive care unit in profound shock, both developed multiple organ failure,
and one patient died.
Conclusions: GAS may produce virulence factors that cause host tissue pathology. Besides aggressive modern
intensivecare treatment,early diagnosis and correctchoice of anti-streptococcalantibiotics are crucial. A possible
adverse effect of non-steroidal anti-inflammatory agents requires confirmation in a multicenter study.
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INTRODUCTION
Puerperal sepsis is a preventable postpartal compli-
cation, if early signs are recognized and treated
adequately.Themost seriouspostpartalinfectionis
the streptococcal toxic shock syndrome (TSS),
characterized by the sudden onset of septic shock
with multiple organ failure and the isolation of
group A b-hemolytic streptococci (GAS) from a
normally sterile body site. The dramatic nature of
this severe, life-threatening infection is illustrated
by the following two cases. Knowledge of
the pathomechanism of invasive streptococcal
infections might help to understand the course of
this disease.
CASE 1
After normal vaginal delivery of a healthy boy, the
first patient (gravida two, para two) developed
fever, combined with a macular rash especially of
the trunk, 3 days postpartum. She was given
non-steroidal anti-inflammatory drugs (NSAIDs)
against her fever and was discharged home early
with the diagnosis of German measles (Figure 1).
Seven days postpartum she was readmitted with
the features of septic shock: hypotension, tachy-
cardia, tachypnea, and pyrexia. She was put on
metronidazole in combination with mezlocillin.
Despite treatment with fluids and vasoactive drugs
underearly invasive hemodynamicmonitoringshe
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Case report 217progressed to organ dysfunction (Table 1). The
abdomen was soft; the uterus was bulky,
anteverted,andtender.Sincethefocusofinfection
was considered to be the uterus, a hysterectomy
was performed. When the diagnosis of a Group A
b-hemolytic streptococcal infection was con-
firmed from bloodculturesand abdominal swabs –
bothtaken on thedayofadmission to theintensive
care unit(ICU) (day 1) – penicillin G was addedto
the antimicrobial regimen 24 hours later. Thiswas
done because the activity of Penicillin G against
GAS is fourtimes the activity of Mezlocillin. With
regard to surgery, it was decided against a narrow-
ing of antimicrobial therapy. Her stay in the
ICU was initially characterized by septic shock,
disseminated intravascular coagulation (DIC), and
multiple organfailure, includingacuterenalfailure
with the need for continuous veno-venous
hemofiltration. The severity and course of illness
are depicted in Figures 2 and 3, respectively.
Secondary, left ventricular decompensation due to
post-streptococcal myocarditis and critical illness
polyneuropathy characterized her further stay in
the ICU. After 28 days, she returned to the ward
prior to discharge home.
CASE 2
The second patient (gravida two, para one) was
admittedto thelaborward withpremature rupture
of membranes in week 38 of gestation. She
delivered vaginally a healthy girl within 24 hours
after rupture of membranes. She did not receive
any antimicrobial therapy. Three days later she
complained of a frontal headache and muscle ache
in all limbs combined with a fever up to 39.5°C
that was treated initially with a NSAID. When she
became stuperous another 3 days later she was
transferred to a neurological ICU with the diag-
nosis of meningitis. On admission she was
comatose, in severe shock and needed immediate
intubation (Table 1). Aggressive organ support
was initiated immediately. A computed cranial
tomogram was normal, the cerebrospinalfluid was
clear, she showed 158/3 cells with an increase in
granulocytes, 584 mg/l protein, and a massive
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Figure 1 Patient 1 on readmission: petechial rash of
right foot
Patient 1 Patient 2
Characteristics Day 1 Day 2 Day 1 Day 2
Temperature (°C)
Pulse rate (bpm)
Blood pressure (mmHg)
White blood cell count (109/l)
Urine output (ml/6h)
40.1
192
80/40
8.9 (29% bands)
45
39
180
100/50
8.6
130
40.4
160
70/30
21.7
70
39.4
180
110/50
12.4
—
Table 1 Patient characteristics on admission (day 1) and after 1 day of aggressive supportive intensive care therapy
(day 2)elevated lactate. For streptococcal TSS (puerperal
sepsis) she was directly administered piperacillin,
sulbactam, and clindamycin for 6 days. After
24 hours gram-positive, catalase-negative cocci
were grown from two vaginal swabs and blood
culturesconfirmed thediagnosis.Thecoloniesdis-
played a strong b-haemolysis; classification of the
bacteria, which had been identified as Streptococcus
pyogenes, detected Lancefield Group A antigen.
Sequencingoftheemmgenerevealed type77/27L.
The genes for the exotoxins SPE C and SPE F
could be detected by polymerase chain reaction.
Multiple organ failure (cardiovascular, respiratory,
renal) and DIC had already been established at
admission to the ICU. Acute anuric renal failure
indicated continuous venovenous hemofiltration
from day 2 onwards. Severely compromised respi-
ratory and cardiovascular function necessitated
continuoustherapeutic intervention. The severity
and the course of illness are again demonstrated by
Figures 2 and 3. Organ functions stabilized after
12 days but then, unfortunately, she had massive
infratentorial bleeding which lead to brain death
on day 16.
DISCUSSION
Puerperal infection due to GAS became a rare
disease in the 20th century. In recent years GAS
have been more important as a cause of perinatal
maternal mortality, and in the last decade there has
beenagain anincreaseofGASinfection1. Theonly
prospective population-based surveillance of
invasive GAS disease was performed in Canada in
1992–32. Invasive GAS disease was defined by the
isolationofS.pyogenesfromanormallysterile body
site. The annual incidence of GAS was 1.5 cases
per 100 000 population; the rate for puerperal
GAS sepsis was 0.5 infections per 10 000 deliver-
ies; and 0.2 GAS infections per 10 000 met the
criteria for streptococcal toxic shock syndrome
(streptococcal TSS) (Table 2)3. Here the overall
mortality rate was 81%.
As is shown by our cases, early signs and symp-
toms of puerperalsepsis dueto GAS are apparently
untypical and are often misinterpreted due to the
lowincidenceofthis fulminating disease (Table 3).
Both patients received NSAIDs against their
unspecific symptoms. In case 1 the diagnosis was
made 4 days after the occurrence of an erythema
and in case 2, 3 days after the onset of the first
symptoms. In our two cases, diagnosis of GAS was
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Figure 2 Course of Acute Physiology and Chronic
Health Evaluation (APACHE) II scores
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Figure 3 Course of Multiple Organ Dysfunction
Scores (MODS)
A IsoIation of group A streptococcus
(1)
(2)
From a sterile site
From a non-sterile body site
B Clinical signs of severity
(1)
(2)
Hypotension
Clinical and laboratory abnormalities (requires
two or more of the following:
(a)
(b)
(c)
(d)
(e)
(f)
Renal impairment
Coagulopathy
Liver abnormalities
Acute respiratory distress syndrome
Extensive tissue necrosis, i.e. necrotizing
fasciitis
Erythematous rash)
Definite case: A1 + B(1+2)
Probable case: A2 + B(1+2)
Table 2 Streptococcal toxic shock syndrome is
definedas any group A streptococcal infection associated
with the early onset of shock and organ failure
15confirmed by blood cultures and abdominal and
vaginal swabs. At that time both patients suffered
already from septic shock according to ACCP/
SCCM criteria4 and multiple organ failure. To
demonstrate the severity and the course of illness
and organ dysfunction we applied the Acute
Physiology and Chronic Health Evaluation
(APACHE) II and the Multiple Organ Dys-
function Score (MODS) (Figures 2 and 3). The
APACHE II model uses information on physio-
logical variables, age, surgical status, and previous
health status to assign a score to the patient
(Table 4). TheAPACHEII is themost commonly
used outcome prediction model5. The organ
failure scores were developed to quantify organ
failure in critically ill patients. A commonly used
score is the Multiple Organ Dysfunction Score
(MODS). This sophisticated score describes
increasing dysfunction of individual organs,
measured as a continuum ranging from normality
through dysfunction to complete failure6.
GAS may produce virulence factors that cause
host tissue pathology.These virulence factorshave
been grouped into four families: adhesins,
aggressins (i.e. streptolysin O), impedins (i.e.
superantigens), and invasins. The streptococcal
pyrogenic exotoxins (SPEs) are polypeptides,
produced by certain group A streptococci and
belong to the group of substances known as
superantigens7. They have the capacity to super-
stimulate theimmune system and thereby inducea
cascade of cytokines. The action of cytokines is
assumed to be responsible for the induction of
the TSS. Superantigens such as the streptococcal
pyrogenic exotoxins do not require processing by
antigen-presenting cells before they can stimulate
T-cells. These superantigens cause an aberrant
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Clinical signs suggestive of puerperal sepsis
Pains: symphyseal, limbs, joints, sore throat, headache
Malaise, flu-like symptoms
Short fever, or none
Erythematous rash
Obstipation, diarrhoea
Acral mottling
Altered mental state
Tachycardia
Table 3 Early clinical signs suggesting puerperal sepsis
APS/points +4 +3 +2 +1 0 +1 +2 +3 +4
Temperature (°C)
Mean arterial pressure
(mmHg)
Heart rate (bpm)
Respiratory rate
(per minute)
Oxygenation: if FiO2 ‡
0,5A: AaDO2
FiO2< 0,5: PaO2
(mmHg)
Arterial pH
Na+(mmol/l)
K+(mmol/l)
Creatinine (mg/dl)
(acute renal failure: ´ 2)
Hematocrit (%)
White blood cells (109/ l)
15 – Glascow Coma Scale
‡ 41
‡ 160
‡ 180
‡ 50
‡ 500
‡ 7.7
‡ 180
‡ 7
‡ 3.5
‡ 60
‡ 40
39–40.9
130–159
140–179
35–49
350–499
7.6–7.69
160–179
6–6.9
2–3.4
110–129
110–139
200–349
155–159
1.5–1.9
50–59.9
20–39.9
38.5–38.9
25–34
7.5–7.59
150–154
5.5–5.9
46–49.9
15–19.9
36–38.4
70–109
70–109
12–24
< 200
> 70
7.33–7.49
130–149
3.5–5.4
1.6–1.4
30–45.9
3–14.9
34–35.9
10–11
61–70
3.3–3.4
32–33.9
50–69
55–69
6–9
7.25–7.32
120–129
2.5–2.9
< 0.6
20–29.9
1–2.9
30–31.9
40–54
55–60
7.15–7.24
111–119
£ 29.9
£ 49.9
£ 39
£ 5
< 55
<  7.15
£ 110
< 2.5
< 20
< 1
Table 4 The APACHE II is the most commonly used outcome prediction model. Acute Physiology Score (APS), the
largest component of the APACHE II score, is derived from 12 clinicalmeasurements that are obtained within 24 hours
after admission on the ICU. The most abnormal measurement is selected to generate the APS component
5proliferation of specific T-cell subsets and can
directly activate thousands of times more T-cells
(up to 25% of the total T-cell population) than
conventional antigens, to produce an accelerated
cascadeofcytokinessuchasinterleukinsandtumor
necrosis factor (TNF)8. At this stage, antibiotics
alone can’t control GAS infection.
Additionally we would like to report on an
observation concerningNSAIDs. We have treated
seven patients with proven GAS-TSS either as
puerperal sepsis or as necrotizing fasciitis. All
patientshad ingested NSAIDs while showingearly
signs of their illness. For us it is suggestive that
NSAIDs taken at the early stage of invasive GAS
infection may accelerate the cascade systems
and play a contributory role in the onset of
shock, organ failure, cytokine production, and
inflammation9. This observation would require
confirmation in a multicenter study.
Other streptococcal factors, such as streptolysin
O, contribute to production of TSS because this
substance can, at least in vitro, induce TNF and
seems to function synergistically with exotoxin10.
Due to their virulence factors, GAS spread rapidly
andstimulate thecascadesystems maximally11.The
uterusmightbe thesite of initial infection butafter
the rapid hematological spread the uterus is no
longer considered the focus of infection. There-
fore currently hysterectomy is not part of first-line
treatment.With streptococalTSSduetopuerperal
sepsis a patient should be stabilized within 24–48
hours. If a patient’s condition deteriorates despite
adequate intensive care therapy (antibiotics: peni-
cillin G and clindamycin, and support of failing
organs), hysterectomy should be performed12.
The therapeutic management of severe GAS
infections requires high doses of intravenous
antibiotics. Penicillin G traditionally has been the
agent of choice, because there is no high-level
resistance among the group A streptococci.
Patients allergic to penicillin may be treated with a
first-generation cephalosporin, vancomycin, or
clindamycin. Recently, clindamycin has been
recommended in addition to penicillin for all
patients. Experimental evidence indicates that
clindamycin may be more effective than penicillin
atinhibitingtheseorganismswhentheyarepresent
in a high inoculum and not dividing rapidly.
Evidence comes from in vitro observation of the
‘Eagle effect’ as well as animal models. Harry Eagle
first showed that streptococci present at high
inoculum(> 107 cfu/mL) are very slowly killed by
penicillin. Animal models suggest that clinda-
mycin, with its inhibition of protein synthesis, has
greater activity than penicillin against organisms in
a stationary phase of growth and may reduce
production of toxins, and TNF13. Clindamycin
aloneisnotrecommendedbecausesomestrainsare
resistant, especially inregionswheremacrolidesare
used extensively in outpatients. Invasive strepto-
coccal TSS is fulminating and may not respond to
delayed antibiotic therapy; therefore it is obvious
that antibiotics and aggressive intensive care treat-
ment should be started as early as possible.
Immunoglobulin preparations have been given
to patients with the intention of neutralizing the
streptococcal toxins, but none of the reports on
this practice is conclusive14. However, ordinary
human immunoglobulin preparations contain
considerable amounts of toxin-neutralizing anti-
bodies and, given at an early stage of invasive
disease, mighthaveabeneficial effect15.Nohuman
studies on intravenous immunoglobulins for
streptococcalTSShavebeenperformedsofar.And
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Characteristic/points 0 1 2 3 4
PaO2/FiO2
Serum creatinine (mg/dl)
Serum bilirubin (mg/dl)
PAR
Platelet count (per mL)
Glascow Coma Score*
> 300
< 1.1
< 1.19
< 10
> 120
15
226–300
1.11–2.29
1.2–3.5
10.1–15
81–120
13–14
151–225
2.3–3.99
3.51–7
15.1–20
51–80
10–12
76–150
4–5.7
7.01–14
20.1–30
21–50
7–9
< 76
> 5.7
> 14
> 30
< 21
< 7
Table 5 The Multiple Organ Dysfunction Score (MODS); PAR, pulse-adjusted heart rate = HR x (RAP/MAP); HR,
heart rate; RAP, right atrial pressure; MAP, mean arterial pressure; *the best estimate in the absence of sedation
6there is still no evidence for the use of other
experimental approaches like the application of
anti-TNF and plasmapheresis, respectively.
Conclusion: currently, an otherwise healthy
patient, with rapid onset of shock and fever even
after an otherwise normal delivery is at least likely
to suffer from streptococcalTSS. In the absence of
effective methods of prevention of this devastating
disease, a high index of suspicion, prompt
initiation of antibiotic therapy with agents that
suppress toxin production, and aggressive organ-
supporting intensive care therapy constitute our
best weapons to fight TSS.
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